SCHEMBL13643003

SCHEMBL13643003

N#Cc1ccc(-c2cc(-c3ccccc3)c3cc(-c4ccccc4)c4ccccc4c3n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 2/20 0.51
▸ ABCB1 P08183 1/20 0.51
▸ MYC P01106 1/20 0.48
▸ SQOR Q9Y6N5 3/20 0.48
▸ GABRA1 P14867 1/20 0.48
▸ GABRG2 P18507 1/20 0.48
▸ GABRB3 P28472 1/20 0.48
▸ GABRA5 P31644 1/20 0.48
▸ GABRA3 P34903 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ADORA1 P30542 5/20 0.47
▸ ADORA2A P29274 4/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ ALDH1A3 P47895 1/20 0.45
▸ ACACA Q13085 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ PIM1 P11309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13642866 1.00 ABCG2 (0.51) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13643179 1.00 ABCG2 (0.51) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13642959 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13643104 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13642961 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13643107 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13642812 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13642867 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13643007 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1
SCHEMBL13083891 0.99 ABCG2 (0.50) ABCG2ABCB1MYCSQORGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 — — US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 — — US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 — — US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 ABCG2 2864/4885ABCB1 905/4885MYC 1711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback